Hobbs Group Advisors LLC Has $484,000 Holdings in CME Group Inc. $CME

Hobbs Group Advisors LLC cut its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 8.3% during the second quarter, Holdings Channel.com reports. The firm owned 1,756 shares of the financial services provider’s stock after selling 159 shares during the quarter. Hobbs Group Advisors LLC’s holdings in CME Group were worth $484,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Concurrent Investment Advisors LLC raised its holdings in shares of CME Group by 132.6% in the second quarter. Concurrent Investment Advisors LLC now owns 12,626 shares of the financial services provider’s stock valued at $3,480,000 after purchasing an additional 7,198 shares during the last quarter. Johnson Investment Counsel Inc. acquired a new stake in shares of CME Group in the second quarter valued at approximately $289,000. waypoint wealth counsel raised its holdings in shares of CME Group by 8.3% in the second quarter. waypoint wealth counsel now owns 930 shares of the financial services provider’s stock valued at $256,000 after purchasing an additional 71 shares during the last quarter. Apollon Wealth Management LLC raised its holdings in shares of CME Group by 7.7% in the second quarter. Apollon Wealth Management LLC now owns 13,295 shares of the financial services provider’s stock valued at $3,664,000 after purchasing an additional 949 shares during the last quarter. Finally, Natural Investments LLC grew its stake in shares of CME Group by 29.8% in the second quarter. Natural Investments LLC now owns 1,315 shares of the financial services provider’s stock valued at $362,000 after buying an additional 302 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. UBS Group decreased their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research note on Monday, September 8th. Jefferies Financial Group decreased their target price on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research note on Friday. TD Cowen raised their target price on shares of CME Group from $281.00 to $288.00 and gave the company a “hold” rating in a research note on Wednesday. Piper Sandler raised their target price on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. Finally, Oppenheimer raised their target price on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $281.00.

Check Out Our Latest Research Report on CME Group

Insider Buying and Selling at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the sale, the insider owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William R. Shepard bought 262 shares of CME Group stock in a transaction dated Thursday, September 25th. The stock was acquired at an average cost of $265.19 per share, with a total value of $69,479.78. Following the transaction, the director owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This trade represents a 0.10% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders sold 13,043 shares of company stock worth $3,527,956. Insiders own 0.30% of the company’s stock.

CME Group Trading Up 1.0%

CME stock opened at $271.45 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a fifty day moving average price of $268.89 and a two-hundred day moving average price of $271.22. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79. The stock has a market cap of $97.83 billion, a price-to-earnings ratio of 26.28, a price-to-earnings-growth ratio of 5.72 and a beta of 0.41.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the previous year, the business posted $2.56 earnings per share. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is 48.40%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.